• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Hygienic Packaging Technology

    Trends in Solid Oral Dosage Delivery

    5 Reasons Paper Has No Place in Contract Manufacturing

    Injectable Drug Delivery Trends

    Pharmaceutical Manufacturing Equipment Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Jubilant Therapeutics Appoints Chief Scientific Officer

    Iontas and Fair Journey Biologics Partner with Quell Therapeutics

    Vetter Establishes Office in China

    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Vetter Establishes Office in China

    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production

    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

    Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Reed-Lane Facility Virtual Tour

    Hygienic Packaging Technology

    Reshaping the Pharmaceutical Supply Chain

    Serialization: Level 5 Solution

    Covectra Introduces Next-Gen Serialization Solution
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Vetter Establishes Office in China

    Data Management Trends

    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production

    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Guide to Maintaining Validation of Older Facilities: Why, When and How

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    PCI Pharma Services

    Emergent BioSolutions

    Baxter BioPharma Solutions

    Syngene

    Adare Pharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Reed-Lane

    Cytovance Biologics

    Alcami

    Adare Pharma Solutions

    Emergent BioSolutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    TFF Pharmaceuticals Signs Worldwide Licensing Agreement with Union Therapeutics

    Will develop dry powder forms of niclosamide as a potential COVID-19 treatment.

    Related CONTENT
    • Celonic to Boost Cell & Gene Therapy Production
    • Aptamer Extends Collaboration with AstraZeneca
    • Amgen to Acquire Five Prime Therapeutics for $1.9B
    • Spark Therapeutics Appoints CTO
    • High Purity New England Bolsters Biopharma Solutions Services
    Contract Pharma Staff08.17.20
    TFF Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, has entered into a worldwide exclusive licensing agreement with Union Therapeutics A/S for its TFF technology used in combination with niclosamide.
     
    Under the terms of the agreement, Union will acquire an option to obtain a worldwide exclusive license of TFF Pharmaceuticals to its TFF technology to be used in the field of niclosamide, including oral and inhalation versions of niclosamide, potentially for COVID-19, as well as other niclosamide-based therapies. Subject to Union’s exercise of its option, it has agreed to pay TFF Pharmaceuticals potential development, regulatory and sales-related milestone payments of up to $210 million. Union will also pay TFF tiered single-digit royalties on product sales. TFF Pharmaceuticals and Union have agreed to collaborate on securing government support with the aim of funding the development of niclosamide-based products for the treatment of COVID-19.
     
    What is Niclosamide?
     
    Niclosamide is an oral anthelminthic drug, first approved by the FDA for use in humans in 1982. It has been used to safely treat millions of patients. More recently, niclosamide has been identified as a multifunctional drug, via drug repurposing screens, with potential to be repurposed to treat a variety of viral infections such as severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), Zika virus (ZIKV), and others, given its inexpensive cost and low in-vivo toxicity profile as an FDA-approved drug in clinical use. Niclosamide has been shown to exhibit potent antiviral activity against SARS-CoV-23, however it has limited aqueous solubility as well as low absorption and oral bioavailability creating challenges for its development as a potential anti-viral therapy. TFF Pharmaceuticals’ TFF technology has demonstrated improvements to the solubility of oral forms of niclosamide as well as to dry powder forms of the drug for delivery directly to the lungs.
     
    “We are very excited to be entering into this agreement with Union therapeutics, a company that has had an extensive history working with niclosamide and the compound class in a number of therapeutic areas,” said Glenn Mattes, president and CEO of TFF Pharmaceuticals. “We believe this agreement will help speed up efforts to investigate the promising use of niclosamide for potential COVID-19 therapies using our breakthrough TFF technology to provide a viable therapeutic option with a new delivery method.”
     
    Union has worked with niclosamide and the related chemical class for over six years and is currently conducting a Phase 2b study with niclosamide in atopic dermatitis patients. The company has built extensive knowledge and intellectual property rights around the compound class, formulations and various methods of delivery as well as broadening the pipeline to cover additional diseases within inflammation and infection.
     
    “Our hope is for the consolidated efforts under the agreement to enable Union to leverage our extensive knowledge of niclosamide and further accelerate the development of treatment options to a broader range of COVID-19 patients,” said professor and CSO and co-founder of Union, Morten Sommer. “We look forward to working with the team at TFF Pharmaceuticals to leverage the TFF technology platform in bringing new treatment options to COVID-19 patients.”
    Related Searches
    • Formulation Development
    Suggested For You
    Celonic to Boost Cell & Gene Therapy Production Celonic to Boost Cell & Gene Therapy Production
    Aptamer Extends Collaboration with AstraZeneca Aptamer Extends Collaboration with AstraZeneca
    Amgen to Acquire Five Prime Therapeutics for $1.9B Amgen to Acquire Five Prime Therapeutics for $1.9B
    Spark Therapeutics Appoints CTO Spark Therapeutics Appoints CTO
    High Purity New England Bolsters Biopharma Solutions Services High Purity New England Bolsters Biopharma Solutions Services
    CatSci Opens New Site in UK CatSci Opens New Site in UK
    Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement  Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement
    Aevitas Therapeutics Appoints President and CEO Aevitas Therapeutics Appoints President and CEO
    Eurofins Scientific Acquires Beacon Discovery Eurofins Scientific Acquires Beacon Discovery
    Century Therapeutics Significantly Expands Capabilities Century Therapeutics Significantly Expands Capabilities
    Biomunex, Onward Ink Strategic Antibody Development Pact   Biomunex, Onward Ink Strategic Antibody Development Pact
    Molecular Templates, BMS Enter Strategic Research Pact Molecular Templates, BMS Enter Strategic Research Pact
    AbbVie, Caribou Ink CAR-T Collaboration AbbVie, Caribou Ink CAR-T Collaboration
    Thermo Fisher, JW Therapeutics Form CAR-T Partnership in China Thermo Fisher, JW Therapeutics Form CAR-T Partnership in China
    Catalent, Trizell Enter Cell Therapy Deal Catalent, Trizell Enter Cell Therapy Deal

    Related Breaking News

    • APIs | Breaking News | Formulation Development | Industry News
      Tris Pharma, Athena Bioscience Enter Exclusive License Agreement

      Tris Pharma, Athena Bioscience Enter Exclusive License Agreement

      Athena gains exclusive rights to commercialize a long-acting antihypertensive product developed using Tris' proprietary technology.
      Kristin Brooks 02.22.21

    • Breaking News | Formulation Development | Industry News | Promotions & Moves
      Novartis Vet Joins CDMO Sai Life Sciences

      Novartis Vet Joins CDMO Sai Life Sciences

      Mahavir Prashad named as vice president of early phase process development.
      Tim Wright, Editor, Contract Pharma 02.17.21

    • APIs | Breaking News | Drug Development | Formulation Development | Industry News | Solid Dosage/Creams/Ointments
      Lonza Expands Solid Small Molecule Services

      Lonza Expands Solid Small Molecule Services

      To encompass all aspects of solid form screening and characterization of small molecule APIs.
      Kristin Brooks 02.16.21


    • Breaking News | Formulation Development | Industry News | Methods Development
      Adare Pharma Solutions Opens New Small-Scale Lab

      Adare Pharma Solutions Opens New Small-Scale Lab

      Vandalia, OH lab offers customizable, flexible systems designed to expedite formulation and process development services.
      Kristin Brooks 01.26.21

    • Breaking News | Formulation Development | Industry News
      Hovione Launches ASD-HIPROS

      Hovione Launches ASD-HIPROS

      Advanced tool designed to identify optimal and commercially viable Amorphous Solid Dispersions formulation by Spray Drying.
      Contract Pharma Staff 01.12.21

    • Biologics, Proteins, Vaccines | Breaking News | Fill/Finish | Formulation Development | Industry News
      Moderna, Recipharm Enter COVID-19 Vax Mfg. Agreement

      Moderna, Recipharm Enter COVID-19 Vax Mfg. Agreement

      Recipharm to provide aseptic drug product manufacturing and fill-finish of Moderna’s COVID-19 vaccine outside of the U.S.
      Contract Pharma Staff 01.04.21


    • Breaking News | Drug Development | Formulation Development | Industry News
      Vectura, Kinaset Partner to Develop Asthma Treatment

      Vectura, Kinaset Partner to Develop Asthma Treatment

      Licenses VR588 to Kinaset, Vectura will provide formulation development services to support Phase I studies and ultimately commercialization.
      Contract Pharma Staff 11.30.20

    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Formulation Development | Industry News
      Lonza Expands Development, Mfg. Capabilities at Bend Site

      Lonza Expands Development, Mfg. Capabilities at Bend Site

      Investment will add 11 new suites for particle engineering and drug product capacity to improve program lead times.
      Contract Pharma Staff 11.30.20

    • Analytical Services | Breaking News | Formulation Development | Industry News | Laboratory Testing
      Cambrex Completes Edinburgh Expansion

      Cambrex Completes Edinburgh Expansion

      Doubles the facility's footprint to 15,000 sq.-ft., existing lab space is refurbished, and an additional 3,500 sq.-ft. of lab space added.
      Contract Pharma Staff 10.12.20


    • Breaking News | cGMP Manufacture | Formulation Development | Industry News | Scale-up/Technology Transfer
      Catalent Launches OneXpress Solution

      Catalent Launches OneXpress Solution

      Aims to accelerate a program’s transition from early-phase development to commercial-ready manufacturing for oral dosage products.
      Contract Pharma Staff 10.01.20

    • Breaking News | cGMP Manufacture | Formulation Development | Industry News | Process Development
      Thomas Lee Partners, Frazier Healthcare Acquires Adare Pharmaceuticals

      Thomas Lee Partners, Frazier Healthcare Acquires Adare Pharmaceuticals

      Includes Adare’s CDMO, pharmaceutical technology and microbiome businesses; will rebrand as Adare Pharma Solutions.
      Contract Pharma Staff 09.30.20

    • APIs | Breaking News | cGMP Manufacture | Chemistry | Drug Development | Excipients | Formulation Development | Industry News
      Piramal to Deliver Integrated Services to Epirium

      Piramal to Deliver Integrated Services to Epirium

      Includes formulation development, supply of APIs and intermediates, chemistry development and manufacturing, and solid oral dosage form drug product.
      Contract Pharma Staff 08.27.20


    • Biologics, Proteins, Vaccines | Breaking News | Fill/Finish | Formulation Development | Industry News
      Dalton, VIDO-InterVac Partner to Develop COVID-19 Vax

      Dalton, VIDO-InterVac Partner to Develop COVID-19 Vax

      Dalton to provide formulation and fill/finish of VIDO-InterVac’s COVID-19 vaccine to be used in early phase clinical trials.
      Contract Pharma Staff 07.28.20

    • Breaking News | Drug Development | Formulation Development | Industry News | Laboratory Testing | Methods Development
      MilliporeSigma Opens M Lab Collaboration Center in Shanghai

      MilliporeSigma Opens M Lab Collaboration Center in Shanghai

      Offers customizable solutions to help advance drug development, including pilot scale and process development support labs that offer non-GMP lab space.
      Contract Pharma Staff 07.10.20

    • Breaking News | Collaborations & Alliances | Formulation Development
      Vectura Earns $5M Novartis Milestone for Enerzair Breezhaler

      Vectura Earns $5M Novartis Milestone for Enerzair Breezhaler

      Enerzair Breezhaler uses Vectura’s formulation IP, and is a first-in-class fixed-dose combination maintenance treatment for uncontrolled asthma.
      Contract Pharma Staff 07.07.20

    Trending
    • Baxter Biopharma Solutions Enters Sterile Manufacturing Agreement For Novavax’ COVID-19 Vaccine
    • Four Female Leaders Appointed To Cell & Gene CDMO
    • Pharmaron Acquires Biomanufacturing Site In The UK From AbbVie
    Breaking News
    • Jubilant Therapeutics Appoints Chief Scientific Officer
    • Iontas and Fair Journey Biologics Partner with Quell Therapeutics
    • Vetter Establishes Office in China
    • AGC Biologics Expands Cell and Gene Facility in Italy
    • Celonic to Boost Cell & Gene Therapy Production
    View Breaking News >
    CURRENT ISSUE

    March 2021

    • Hygienic Packaging Technology
    • Trends in Solid Oral Dosage Delivery
    • 5 Reasons Paper Has No Place in Contract Manufacturing
    • Injectable Drug Delivery Trends
    • Pharmaceutical Manufacturing Equipment Trends
    • Oral Solids: Market & Technology Trends
    • Nutraceutical Manufacturing: Meeting the Challenges of Today, Planning for Tomorrow
    • 2021 Contract Manufacturing Survey
    • Small Molecule Development Trends
    • Challenges & Opportunities Facing Small & Emerging Biopharma Companies
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Diets High In Fructose Could Cause Immune System Damage
    Nestlé Acquires Premium Water Brand Essentia
    Kaneka Probiotics Announces Launch of L. plantarum DR7
    Coatings World

    Latest Breaking News From Coatings World

    Sherwin-Williams Announces Resignation of President, COO
    Ashland Completes Expansion, Relocation of Viatel Bioresorbable Polymers Manufacturing Facility
    Evonik Receives Sustainability Award from EcoVadis
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs First OTC Home Molecular COVID-19 Test
    FDA Approves Second Sight's Argus 2s Retinal Prosthesis
    Cross Border Venture Financing Rose in Final Quarter of 2020
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Sharp Appoints EU Qualified Person
    Baxter Biopharma Solutions Enters Sterile Manufacturing Agreement for Novavax’ COVID-19 Vaccine
    Metrics Contract Services Completes Russian Regulatory Inspection
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    It's International Women's Day—But What Does That Mean?
    e.l.f. Cosmetics and Chipotle Collaborate on Burrito-Inspired Makeup Collection
    Weekly Recap: Sephora Expansion, Ulta Partners with Loop, International Women’s Day & More
    Happi

    Latest Breaking News From Happi

    Cococare Appoints First Woman President
    Ross Highlights Triple Shaft Mixers
    Arm & Hammer Unveils Foot Wipes
    Ink World

    Latest Breaking News From Ink World

    Capital Printing Invests in 2nd Komori Press
    Arna Marketing Adds Canon’s ProStream, VarioPRINT iX Production Inkjet Presses
    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Xeikon details upcoming Xeikon Café TV seminars
    Resource Label Group acquires New England Label
    UV+EB-cured products rated 'easier to recycle'
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Arm & Hammer Launches Foot Wipes
    Kimberly-Clark Names Chief Research and Development Officer
    FPInnovations Develops Biodegradable Mask
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Australia Clears Conformis' iTotal PS Knee Replacement System
    Colfax Decides to Divide Its Businesses
    Stryker Corp.'s 2020 Sales Slip 3.6 Percent
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research
    Wearable Patch Market to Reach $27.8 Billion by 2027: Allied Market Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login